These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 33426788)
1. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation. Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788 [TBL] [Abstract][Full Text] [Related]
2. Eplet Mismatch Load and Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139 [TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Duquesnoy RJ Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832 [TBL] [Abstract][Full Text] [Related]
4. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation. Argani H Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521 [TBL] [Abstract][Full Text] [Related]
5. Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software. Tassone G; De Santis D; Vukovic I; Downing J; Martinez OP; D'Orsogna LJ HLA; 2020 Jul; 96(1):52-63. PubMed ID: 32281731 [TBL] [Abstract][Full Text] [Related]
6. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes. Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506 [TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry. Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S Front Immunol; 2021; 12():800946. PubMed ID: 35154076 [TBL] [Abstract][Full Text] [Related]
8. Repeated human leukocyte antigens eplets, importance of typing the partner. Dos Reis Ferreira C; da Silva Fernandes VM; Tafulo SCR; Cerqueira A; Rocha ACB; Nunes ATPM; Ferreira IPCN; Santos MJC; Pinho ATMT; Tavares IC; Guerra MMBB; Norton SMMS Transpl Immunol; 2024 Jun; 84():102049. PubMed ID: 38729449 [TBL] [Abstract][Full Text] [Related]
9. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation? Duquesnoy RJ Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632 [TBL] [Abstract][Full Text] [Related]
10. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients. Charnaya O; Jones J; Philogene MC; Chiang PY; Segev DL; Massie AB; Garonzik-Wang J Pediatr Nephrol; 2021 Dec; 36(12):3971-3979. PubMed ID: 34100108 [TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant. Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876 [TBL] [Abstract][Full Text] [Related]
12. Kidney Transplantation With Ultralong-Term (42 Years) Survival of a 100-Year-Old Graft. Nascimento E; Lucas-Junior FM; Fabreti-Oliveira RA; Vilela B; Tavora ER; Silva JP; Salomão-Filho A Transplant Proc; 2016 Nov; 48(9):3079-3084. PubMed ID: 27932151 [TBL] [Abstract][Full Text] [Related]
13. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients. Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771 [TBL] [Abstract][Full Text] [Related]
14. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123 [TBL] [Abstract][Full Text] [Related]
15. Should epitope-based HLA compatibility be used in the kidney allocation system? Duquesnoy RJ Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385 [TBL] [Abstract][Full Text] [Related]
17. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Duquesnoy RJ; Askar M Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708 [TBL] [Abstract][Full Text] [Related]
18. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation. Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248 [TBL] [Abstract][Full Text] [Related]